DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Suven Life Sciences Limited — Outcome of Board Meeting

NSE 48 min ago·5 Nov 2026, 7:59 am

Suven Life Sciences

Suven Life Sciences has informed the stock exchanges that its board has approved the financial results for the period ending September 30, 2026. This is a routine corporate disclosure required for listed companies to keep the market updated on their financial performance.

For investors, this announcement is a key data point that will be scrutinized for signs of growth or stability. The company's performance in the upcoming quarter will be closely watched to gauge its trajectory in the competitive pharmaceutical sector.

Investors should focus on the detailed financial statements released alongside this update to assess the company's operational health and future outlook.